Biblio Discovery — Demo Discovery Service

12 results for "Fong-In Chou"

Showing 1–12 · 0.12 seconds · RSS

  1. Journal Article

    Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor

    Ling-Wei Wang; Yen-Wan Hsueh Liu; Fong-In Chou et al.

    Cancer Communications, Vol. 38 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Head and neck (HN) cancer is an endemic disease in Taiwan, China. Locally recurrent HN cancer after full-dose irradiation poses a therapeutic challenge, and boron neutron capture therapy (BNCT) may be a solution that could provide durable local control with tolerable toxicity. The…

  2. Journal Article Full text

    Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model

    Yu-Chuan Lin; Yi-Jang Lee; Yi-Wei Chen et al.

    Cells, Vol. 11 No. 17 · 2022 · English · DOAJ Scopus

    In clinical boron neutron capture therapy (BNCT), boronophenylalanine (BPA) administrations through one-step infusion (OSI) and two-step infusion (TSI) are the most widely used. This study compared the advantages of OSI and TSI using a human oral squamous cell carcinoma-bearing animal model. OSI…

  3. Journal Article Full text

    Preliminary dosimetric study on feasibility of multi-beam boron neutron capture therapy in patients with diffuse intrinsic pontine glioma without craniotomy

    Jia-Cheng Lee; Keh-Shih Chuang; Yi-Wei Chen et al.

    PLOS ONE, Vol. 12 No. 6 · 2017 · English · PLOS Scopus

    …tumors with an adequate dose while sparing adjacent normal tissue. In this study, 12 consecutive patients treated with conventional radiotherapy in our institute were reviewed to evaluate the feasibility of BNCT. NCTPlan Ver. 1.1.44 was used for dose calculations. Compared with two and three…

    Also available at: DOAJ

  4. Journal Article Full text

    Pharmacokinetics of BPA in Gliomas with Ultrasound Induced Blood-Brain Barrier Disruption as Measured by Microdialysis

    Feng-Yi Yang; Yi-Li Lin; Fong-In Chou et al.

    PLoS ONE, Vol. 9 No. 6 · 2014 · English · PLOS Scopus

    The blood-brain barrier (BBB) can be transiently disrupted by focused ultrasound (FUS) in the presence of microbubbles for targeted drug delivery. Previous studies have illustrated the pharmacokinetics of drug delivery across the BBB after sonication using indirect visualization techniques. In this…

    Also available at: DOAJ

  5. Journal Article Full text

    NeuTHOR Station—A Novel Integrated Platform for Monitoring BNCT Clinical Treatment, Animal and Cell Irradiation Study at THOR

    Yu-Shiang Huang; Jinn-Jer Peir; Chuan-Jen Wu et al.

    Life, Vol. 13 No. 3 · 2023 · English · DOAJ Scopus

    (1) Background: A well-established Boron Neutron Capture Therapy (BNCT) facility includes many essential systems, which are the epithermal neutron beam system, on-line monitoring system (OMS), QA/QC (quality assurance or quality control) system, boron concentration (BC) measurement system, and…

  6. Journal Article Full text

    Therapeutic Efficacy and Radiobiological Effects of Boric-Acid-Mediated BNCT in an Osteosarcoma-Bearing SD Rat Model

    Chen-Fang Hsu; Hong-Ming Liu; Jinn-Jer Peir et al.

    Life, Vol. 13 No. 2 · 2023 · English · DOAJ Scopus

    …OS and reducing radiation damage to adjacent healthy tissues. Methods: In this study, a UMR-106-grafted OS rat model was developed, and boric acid (BA) was used as the boron drug for BNCT. The pharmacokinetics of BA, following intravenous injection, were evaluated to determine the optimal time…

  7. Journal Article

    Targeting SLC7A5 in lung squamous cell carcinoma: implications for cancer metabolism shift and boron neutron capture therapy resistance

    Yen-Ju Lin; Yu-Cheng Wu; Yu-Jui Liu et al.

    Oncogenesis, Vol. 14 No. 1 · 2025 · English · DOAJ Scopus

    …therapy (BNCT), a targeted particle therapy, has shown promising results in various cancers. SLC7A5, a transporter of essential amino acids and boronophenylalanine (BPA) used in BNCT, emerges as a potential therapeutic target. However, its expression across different histological subtypes and the…

  8. Journal Article Full text

    Harnessing Nuclear Energy to Gold Nanoparticles for the Concurrent Chemoradiotherapy of Glioblastoma

    Jui-Ping Li; Yu-Cheng Kuo; Wei-Neng Liao et al.

    Nanomaterials, Vol. 13 No. 21 · 2023 · English · DOAJ Scopus

    Nuclear fission reactions can release massive amounts of energy accompanied by neutrons and γ photons, which create a mixed radiation field and enable a series of reactions in nuclear reactors. This study demonstrates a one-pot/one-step approach to synthesizing radioactive gold nanoparticles (RGNP)…

  9. Journal Article Full text

    Compassionate Treatment of Brainstem Tumors with Boron Neutron Capture Therapy: A Case Series

    Yi-Wei Chen; Yi-Yen Lee; Chun-Fu Lin et al.

    Life, Vol. 12 No. 4 · 2022 · English · DOAJ Scopus

    Brainstem tumors are heterogenous and cancerous glioma tumors arising from the midbrain, pons, and the medulla that are relatively common in children, accounting for 10% to 20% of all pediatric brain tumors. However, the prognosis of aggressive brainstem gliomas remains extremely poor despite…

  10. Journal Article Full text

    Salvage Boron Neutron Capture Therapy for Malignant Brain Tumor Patients in Compliance with Emergency and Compassionate Use: Evaluation of 34 Cases in Taiwan

    Yi-Wei Chen; Yi-Yen Lee; Chun-Fu Lin et al.

    Biology, Vol. 10 No. 4 · 2021 · English · DOAJ Scopus

    …MIB-1 ≤ 40, and a lower recursive partitioning analysis (RPA) class. In conclusion, for malignant brain tumor patients who have exhausted all available treatment options and who are in an immediately life-threatening condition, BNCT may be considered as a therapeutic approach to prolong survival.